Related Experiment Video
Updated: Jul 11, 2025
06:47
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
9.7K
Relieving severe itching caused by scabies with tofacitinib: A case report
Zhenze Yu1, Zhenzhen Wu1, Fang Sun1
1Department of Dermatology Affiliated AoYang Hospital of Jiangsu University Zhangjiagang Jiangsu China.
Clinical Case Reports
|November 13, 2023
Summary
Tofacitinib effectively relieved severe itching caused by scabies. This case suggests tofacitinib as a potential new treatment option for scabies management.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Scabies is a contagious skin infestation causing severe pruritus.
- Current treatments for scabies can be limited by resistance or side effects.
Observation:
- A patient with severe scabies experienced intense itching.
- The patient was treated with tofacitinib, a Janus kinase inhibitor.
Findings:
- Tofacitinib rapidly alleviated the severe itching associated with scabies.
- The treatment demonstrated a significant reduction in pruritus.
Implications:
- Tofacitinib may offer a novel therapeutic approach for scabies.
- This finding could lead to new treatment strategies for refractory scabies cases.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
147
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
147
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170